# Seqirus Inc – FDA Inspection, Jun 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/seqirus-inc/537b3437-a5d5-4d50-acfe-d5c5f30582d9
Source feed: FDA_Inspections

> FDA inspection 1271769 of Seqirus Inc, June 05, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271769
- Company Name: Seqirus Inc
- Inspection Date: 2025-06-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccine, Allergenic, and Live Biotherapeutic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Atlanta District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1172982 - 2022-06-09
- [FDA Inspection 1061837 - 2018-06-18](https://www.keypedia.com/records/fda_inspections/seqirus-inc/4027549a-c56f-482f-8f8f-d3fe1419260f)
- FDA Inspection 968013 - 2016-05-17
- FDA Inspection 860576 - 2013-11-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)
- [FDA Associated Person](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)

Company: https://www.keypedia.com/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7